Ticker: ATNM

**Actinium Pharmaceuticals, Inc. (NYSE: ATNM)** has reported a challenging quarter in its latest quarterly financial statements dated March 31, 2025. Here’s a concise overview of the company’s financial performance alongside its operational highlights. Key Financial Highlights for Q1 2025: No re...